The COVID-19 pandemic caused by SARS-CoV-2 continues to spread rapidly due to its
virulence and ability to be transmitted by asymptomatic infected persons. If they are present …

Background: Coronavirus Disease 2019 (COVID-19)-associated coagulopathy is
characterized by a prothrombotic state not yet comprehensively studied. We investigated the …

The COVID-19 pandemic has caused monumental mortality, and there are still no adequate
therapies. Most severely ill COVID-19 patients manifest a hyperactivated immune response …

Background Critically ill patients diagnosed with COVID-19 may develop a pro-thrombotic
state that places them at a dramatically increased lethal risk. Although platelet activation is …

Severe COVID-19 patients frequently present thrombotic complications which commonly
lead to multiorgan failure and increase the risk of death. Severe SARS-CoV-2 infection …

Accumulating evidence into the pathogenesis of COVID-19 highlights a hypercoagulability
state with high risk of life-threatening thromboembolic complications. However, the …

CORRESPONDENCE plasminogen activator and PAI-1 (plasminogen activator inhibitor-1)
antigen levels were increased in both groups, with significantly higher tissue plasminogen …

Prevalent coagulopathy and thromboembolism are observed in severe COVID-19 patients
with 40% of COVID-19 mortality being associated with cardiovascular complications …

Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), also known as coronavirus
disease 2019 (COVID-19)-induced infection, is strongly associated with various …